Page 29 - Read Online

Page 1162 Brettrager et al. Cancer Drug Resist 2019;2:1153-63 I http://dx.doi.org/10.20517/cdr.2019.91

43. Davies DR, Interthal H, Champoux JJ, Hol WG. Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA,
and a topoisomerase I-derived peptide. Chem Biol 2003;10:139-47.
44. Davies DR, Interthal H, Champoux JJ, Hol WG. Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA
phosphodiesterase using vanadate complexes. J Med Chem 2004;47:829-37.
45. Swarup G, Cohen S, Garbers DL. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys
Res Commun 1982;107:1104-9.
46. Liao Z, Thibaut L, Jobson A, Pommier Y. Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and
ribosome inhibitors. Mol Pharmacol 2006;70:366-72.
47. Huang SN, Pommier Y, Marchand C. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitors. Expert Opin Ther Pat 2011;21:1285-92.
48. Huang HC, Liu J, Baglo Y, Rizvi I, Anbil S, et al. Mechanism-informed repurposing of minocycline overcomes resistance to
topoisomerase inhibition for peritoneal carcinomatosis. Mol Cancer Ther 2018;17:508-20.
49. Chukwudi CU. rRNA binding sites and the molecular mechanism of action of the tetracyclines. Antimicrob Agents Chemother
2016;60:4433-41.
50. Antony S, Marchand C, Stephen AG, Thibaut L, Agama KK, et al. Novel high-throughput electrochemiluminescent assay for
identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an
inhibitor of Tdp1. Nucleic Acids Res 2007;35:4474-84.
51. Banerjee B, Roy A, Sen N, Majumder HK. A tyrosyl DNA phosphodiesterase 1 from kinetoplastid parasite Leishmania donovani
(LdTdp1) capable of removing topo I-DNA covalent complexes. Mol Microbiol 2010;78:119-37.
52. Keil A, Frese-Schaper M, Steiner SK, Korner M, Schmid RA, et al. The Topoisomerase I inhibitor irinotecan and the Tyrosyl-DNA
phosphodiesterase 1 inhibitor furamidine synergistically suppress murine lupus nephritis. Arthritis Rheumatol 2015;67:1858-67.
53. Dexheimer TS, Gediya LK, Stephen AG, Weidlich I, Antony S, et al. 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC
88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors. J Med Chem 2009;52:7122-31.
54. Marchand C, Lea WA, Jadhav A, Dexheimer TS, Austin CP, et al. Identification of phosphotyrosine mimetic inhibitors of human
tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay. Mol Cancer Ther 2009;8:240-8.
55. Sirivolu VR, Vernekar SK, Marchand C, Naumova A, Chergui A, et al. 5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA
phosphodiesterase I. J Med Chem 2012;55:8671-84.
56. Weidlich IE, Dexheimer T, Marchand C, Antony S, Pommier Y, et al. Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1)
developed by virtual screening using ligand-based pharmacophores. Bioorg Med Chem 2010;18:182-9.
57. Gushchina IV, Nilov DK, Zakharenko AL, Lavrik OI, Svedas VK. Structure modeling of human Tyrosyl-DNA phosphodiesterase 1
and screening for its inhibitors. Acta Naturae 2017;9:59-66.
58. Lountos GT, Zhao XZ, Kiselev E, Tropea JE, Needle D, et al. Identification of a ligand binding hot spot and structural motifs
replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail
screening. Nucleic Acids Res 2019;47:10134-50.
59. Das BB, Huang SY, Murai J, Rehman I, Ame JC, et al. PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage.
Nucleic Acids Res 2014;42:4435-49.
60. Murai J, Huang SY, Renaud A, Zhang Y, Ji J, et al. Stereospecific PARP trapping by BMN 673 and comparison with olaparib and
rucaparib. Mol Cancer Ther 2014;13:433-43.
61. Jun JH, Kumar V, Dexheimer TS, Wedlich I, Nicklaus MC, et al. Synthesis, anti-cancer screening and tyrosyl-DNA phosphodiesterase
1 (Tdp1) inhibition activity of novel piperidinyl sulfamides. Eur J Pharm Sci 2018;111:337-48.
62. Zakharenko A, Khomenko T, Zhukova S, Koval O, Zakharova O, et al. Synthesis and biological evaluation of novel tyrosyl-DNA
phosphodiesterase 1 inhibitors with a benzopentathiepine moiety. Bioorg Med Chem 2015;23:2044-52.
63. Khomenko T, Zakharenko A, Odarchenko T, Arabshahi HJ, Sannikova V, et al. New inhibitors of tyrosyl-DNA phosphodiesterase I
(Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties. Bioorg Med Chem 2016;24:5573-81.
64. Li-Zhulanov NS, Zakharenko AL, Chepanova AA, Patel J, Zafar A, et al. A novel class of Tyrosyl-DNA phosphodiesterase 1 inhibitors
that contains the octahydro-2H-chromen-4-ol scaffold. Molecules 2018;23:E2468.
65. Mozhaitsev ES, Zakharenko AL, Suslov EV, Korchagina DV, Zakharova OD, et al. Novel inhibitors of DNA repair enzyme TDP1
combining monoterpenoid and adamantane fragments. Anticancer Agents Med Chem 2019;19:463-72.
66. Zakharova O, Luzina O, Zakharenko A, Sokolov D, Filimonov A, et al. Synthesis and evaluation of aryliden- and hetarylidenfuranone
derivatives of usnic acid as highly potent Tdp1 inhibitors. Bioorg Med Chem 2018;26:4470-80.
67. Zakharenko AL, Luzina OA, Sokolov DN, Kaledin VI, Nikolin VP, et al. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance
the therapeutic impact of topotesmall es, Cyrillican on in vivo tumor models. Eur J Med Chem 2019;161:581-93.
68. Komarova AO, Drenichev MS, Dyrkheeva NS, Kulikova IV, Oslovsky VE, et al. Novel group of tyrosyl-DNA-phosphodiesterase 1
inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy. J Enzyme Inhib Med Chem 2018;33:1415-29.
69. Salomatina OV, Popadyuk, II, Zakharenko AL, Zakharova OD, Fadeev DS, et al. Novel semisynthetic derivatives of bile acids as
effective Tyrosyl-DNA phosphodiesterase 1 inhibitors. Molecules 2018;23:E679.
70. Efremova AS, Zakharenko AL, Shram SI, Kulikova IV, Drenichev MS, et al. Disaccharide pyrimidine nucleosides and their
derivatives: a novel group of cell-penetrating inhibitors of poly(ADP-ribose) polymerase 1. Nucleosides Nucleotides Nucleic Acids
2013;32:510-28.
71. Maltseva EA, Rechkunova NI, Sukhanova MV, Lavrik OI. Poly(ADP-ribose) polymerase 1 modulates interaction of the nucleotide
excision repair factor XPC-RAD23B with DNA via Poly(ADP-ribosyl)ation. J Biol Chem 2015;290:21811-20.
72. Tian LW, Feng Y, Tran TD, Shimizu Y, Pfeifer T, et al. Tyrosyl-DNA phosphodiesterase I inhibitors from the Australian plant
macropteranthes leichhardtii. J Nat Prod 2015;78:1756-60.
73. Tian LW, Feng Y, Tran TD, Shimizu Y, Pfeifer T, et al. Achyrodimer F, a tyrosyl-DNA phosphodiesterase I inhibitor from an Australian